CRP and cancer: In an additional exploratory logistic regression analysis, an increase in CRP implicated, on average, an increased risk for cancer of 2.4% (OR: 1.024, 95% CI: 1.001–1.047; p = 0.041), when the cancer was either a solid cancer or MGUS (n = 8) (Table 6).